2/8/2012

Scottish company Sistemic will collaborate with Ti-Genix and Oxford University scientists in a $7.8 million project to develop cellular therapies for rheumatoid arthritis. Researchers in France, the Netherlands and Spain will participate in the project.

Related Summaries